TICKERNERD
Menu
AMWLAMWLHealthcare · Health Information Services

AMWL Stock Forecast: American Well Corp. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$12
−3.79% on the day

The 7 Wall Street analysts covering American Well Corp. hold a median 12-month price target of $12 — -3.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 80 of 100 as at 13 Aug 2026 — inside the top quartile. The factors read stronger than the Street's target implies. That gap is the story on this page.

Market cap
$220.1M
Ticker Nerd rank
80 / 100
Median analyst target
$12
Analysts covering
7
Total return, dividends reinvested
1W
−7.9%
1M
+14.4%
YTD
+153.6%
1Y
+71.3%
From 52W high
−8.3%
From 52W low
+229.4%
$4
$14
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AMWL stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores American Well Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Aug 2026
80 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
91
Revisions
91
Size
67
Momentum
65
Quality
62
Issuance
58
Growth
52
Value
27
Volatility
23

Accruals (91): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (23): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AMWL stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AMWL, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$6$8$10$12$14$16Oct 25Jan 26Apr 26Jul 26AMWLHigh $16Median $12Low $11

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says7 analysts
1 Buy6 Hold0 Sell
Low $11Median $12High $16

The green dot is the last close — the median target sits −3.6% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
13 Aug 2026Truist SecuritiesMaintainsHold$7.50 → $12
5 Aug 2026NeedhamReiteratesHold—
17 July 2026Wells FargoMaintainsOverweight$9.00 → $16
17 July 2026Wells FargoMaintainsOverweight—
6 May 2026Morgan StanleyMaintainsEqual-Weight$6.00 → $6.50
6 May 2026Morgan StanleyMaintainsEqual-Weight—
6 May 2026TD CowenMaintainsHold—
6 May 2026TD CowenMaintainsHold$5.00 → $8.00
13 Feb 2026StifelMaintainsHold—
18 Dec 2025Morgan StanleyMaintainsEqual-Weight—
5 Nov 2025StifelMaintainsHold—
5 Nov 2025Wells FargoMaintainsOverweight—
7 Aug 2025Wells FargoMaintainsOverweight—
23 May 2025Piper SandlerReiteratesNeutral—
8 May 2025UBSMaintainsNeutral—
2 May 2025NeedhamReiteratesHold—
2 May 2025StifelMaintainsHold—
10 Apr 2025Truist SecuritiesMaintainsHold—
14 Feb 2025Truist SecuritiesMaintainsHold—
13 Feb 2025NeedhamReiteratesHold—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AMWL appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

AMWL analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

American Well Corp. (AMWL) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−2.1×

Cheaper than 85% of US stocks

Price / sales
1.0×

Cheaper than 70% of US stocks

Price / book
1.0×

Cheaper than 74% of US stocks

EV / EBITDA
−1.0×

Cheaper than 67% of US stocks

Growth & margins
Revenue growth (YoY)
−26.6%

Higher than 10% of US stocks

Earnings growth (YoY)
−26.6%

Higher than 17% of US stocks

Gross margin
53.0%

Higher than 66% of US stocks

Operating margin
−19.6%

Higher than 22% of US stocks

Net margin
−35.7%

Higher than 12% of US stocks

Returns & dividend
Return on equity
−29.1%

Higher than 27% of US stocks

Return on assets
−12.6%

Higher than 24% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

AMWL vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
AMWLAmerican Well Corp.$220.1M
80
SPOKSpok Holdings, Inc.$226.6M
62
LFMDLifeMD, Inc.$166.6M
30
OPRXOptimizeRx Corp.$163.0M
83
HCATHealth Catalyst, Inc.$131.7M
52
SLPSimulations Plus, Inc.$370.3M
90
CARLCarlsmed, Inc.$380.3M
19

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own American Well Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AMWL news & analysis

Amwell makes grant to new employees under inducement plan

GlobeNewsWire · 7 Aug 2026neutral

On August 7, 2026, Amwell granted restricted stock units covering 6,679 shares of Class A common stock to two new non-executive employees. The grants were offered as a material inducement for these employees to join the company.

Why it matters — This disclosure reflects Amwell's use of equity incentives to attract new talent, which may be of interest to shareholders tracking the company's compensation practices and share dilution.

American Well Corporation (AMWL) Q2 2026 Earnings Call Transcript

Seeking Alpha · 5 Aug 2026neutral

Seeking Alpha published the transcript of American Well Corporation's Q2 2026 earnings call. The item consists of the earnings call transcript cover page, indicating that the call took place and its transcript is now available.

Why it matters — An AMWL watcher would care because the earnings call transcript offers a record of management's discussion of the company's second-quarter 2026 results and outlook.

American Well Q2 Earnings Call Highlights

MarketBeat · 5 Aug 2026positive

American Well (Amwell) reported second-quarter 2026 revenue of $52 million, down 26.6% year over year, while narrowing its adjusted EBITDA loss and raising its full-year profitability outlook. The company continues to pursue operating and cash-flow breakeven in the fourth quarter.

Why it matters — The quarter shows progress on profitability, with a narrowed loss and an improved full-year outlook, which AMWL watchers would track as a key step toward the company's stated fourth-quarter breakeven goal.

American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates

Zacks Investment Research · 5 Aug 2026positive

American Well Corporation reported a quarterly loss of $0.59 per share, narrower than the Zacks Consensus Estimate of a $0.60 loss and an improvement from a $1.24 per-share loss a year ago. The company also beat revenue estimates, according to the report.

Why it matters — AMWL watchers would care because the company's quarterly results came in better than analyst expectations on both loss per share and revenue.

Amwell® Announces Results for the Second Quarter 2026

GlobeNewsWire · 4 Aug 2026positive

Amwell announced its financial results for the second quarter ended June 30, 2026. Chairman and CEO Dr. Ido Schoenberg highlighted the DHA's stated intent to make Amwell a prime contractor as a powerful endorsement of its platform and people.

Why it matters — AMWL watchers would care because the DHA's intent to make Amwell a prime contractor signals potential expansion and recognition of the company's healthcare platform within a major federal program.

FAQ

Frequently asked questions about AMWL stock

What is the AMWL stock price forecast for 2026-2027?

The 7 Wall Street analysts covering American Well Corp. have a median 12-month price target of $12, with estimates ranging from $11 to $16. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AMWL stock a buy right now?

Of the 7 analysts covering American Well Corp., 1 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks American Well Corp. 80 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AMWL?

As at 13 Aug 2026, American Well Corp. ranks 80 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (91 of 100).

Will AMWL stock go up?

No one can know that. What the data says: the median 12-month target from 7 analysts implies -3.6% from the last close, and Ticker Nerd's factor model ranks American Well Corp. 80 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AMWL stock forecast for 2030?

No analyst covering American Well Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMWL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $11 to $16 over the next 12 months.

How has AMWL stock performed over the past year?

American Well Corp. returned +71.3% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does American Well Corp. do?

American Well Corporation is a prominent player in the telemedicine sector, specializing in the development and deployment of technology-driven healthcare solutions. Its primary purpose is to connect patients with healthcare professionals through video visits, thereby expanding access to medical services and reducing the barriers imposed by traditional, location-based healthcare systems.

What is the latest news on AMWL?

The most recent item we track (GlobeNewsWire, 7 Aug 2026): "Amwell makes grant to new employees under inducement plan". On August 7, 2026, Amwell granted restricted stock units covering 6,679 shares of Class A common stock to two new non-executive employees. The grants were offered as a material inducement for these employees to join the company.

Company

About American Well Corp.

American Well Corporation is a prominent player in the telemedicine sector, specializing in the development and deployment of technology-driven healthcare solutions. Its primary purpose is to connect patients with healthcare professionals through video visits, thereby expanding access to medical services and reducing the barriers imposed by traditional, location-based healthcare systems. This corporation provides a platform that facilitates secure and efficient virtual communication between patients and doctors, which is particularly vital in remote or underserved areas. American Well's technology is employed across a variety of healthcare settings, including hospitals, health plans, and employers, striving to enhance the patient experience and improve outcomes. The company plays an essential role in the digital health transformation by leveraging telehealth to meet growing demand for more flexible and accessible healthcare delivery. Established as a leader in the telemedicine industry, American Well's influence extends across both the public and private sectors, underscoring its significance in the ongoing evolution of healthcare services in today's digital age.

CEO Dr. Ido Schoenberg M.D. · 562 employees · United States · https://business.amwell.com